
Progenity, Inc. PROG
Progenity, Inc. DIO Ratio 2011-2026 | PROG
Annual DIO Ratio Progenity, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 47.7 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.7 | 47.7 | 47.7 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
1.91 K | - | 1.35 % | $ 17.8 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.14 | 0.16 % | $ 653 M | ||
|
Eton Pharmaceuticals
ETON
|
150 | $ 34.42 | 4.65 % | $ 926 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.21 | 4.72 % | $ 5.58 B | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.64 | 0.61 % | $ 436 M | ||
|
Heron Therapeutics
HRTX
|
644 | $ 0.85 | 0.57 % | $ 142 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
185 | - | -4.36 % | $ 27 M | ||
|
Anika Therapeutics
ANIK
|
159 | $ 15.15 | 2.23 % | $ 217 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Coherus BioSciences
CHRS
|
97.5 | $ 1.52 | 2.7 % | $ 178 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 20.45 | 4.9 % | $ 2.6 B |